The Vox Markets Podcast / Neil Clark & Shaun Claydon of Destiny Pharma: Funds raised will be used to accelerate the development of their two lead key assets

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.